Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors
Laboratory and/or medical tests (e.g., serum potassium levels, complete blood count, hematocrit, vitamin B-12 levels) should be performed to monitor your progress or check for side effects
Its synthesized primarily in the liver and kidneys and stored in tissues like skeletal muscles, where it plays a key role in energy production
Trial registration Similar content being viewed by others Introduction Metabolic syndrome (MetS) is defined as a cluster of cardiovascular risk factors (i.e., abdominal obesity, hyperinsulinaemia, atherogenic dyslipidemia, hypertension, hypercogauability) that increase the risk of developing co-existing coronary heart disease (CHD) and type 2 diabetes [1]
Collagen peptides are widely available as dietary supplements